钆匹醇增强儿童脑MRI中的柔脑膜血管性
该回顾性观察研究纳入302例2-18岁儿童增强脑MRI,比较钆匹醇(0.05 mmol/kg)与钆特酸葡胺(0.1 mmol/kg)对背景轴外强化的影响。钆匹醇在所有T1加权序列上与高轴外强化独立相关(OR 10.2-14.0),2D FLAIR上无此效应,提示放射科医生应识别该效应以避免误判为柔脑膜病变。
要点
- 钆匹醇增强儿童脑MRI的T1加权序列上背景轴外强化更明显,3D T1 SE的OR=10.2,3D T1 SPGR的OR=10.7,2D T1 TSE的OR=14.0。
- 2D FLAIR上对比剂无影响,年轻年龄与高强化相关(P=.022),年龄-麻醉交互提示镇静下该效应减弱。
- 观察者间一致性中等至较优(κ=0.530-0.632)。
核心结论
- 钆匹醇增加儿童脑MRI增强后T1加权序列上的背景轴外强化,可能反映其较高弛豫率,放射科医生应知悉此效应以避免误判为柔脑膜病变;增强后FLAIR不受影响,仍可作为检测真性脑膜疾病的可靠序列。
研究设计与样本
- 回顾性观察研究,纳入302例2-18岁患者增强脑MRI,钆匹醇组151例(0.05 mmol/kg)与钆特酸葡胺组151例(0.1 mmol/kg),增强后序列包括3D T1 SE、3D T1 SPGR、2D T1 TSE和2D FLAIR,由两名神经放射科医生基于脑沟强化阈值建立二分类强化类别。
关键影像表现/征象
- 钆匹醇组在T1加权序列上背景轴外强化(脑沟强化)更明显,表现为高强化类别比例更高。
- 2D FLAIR上对比剂无影响,年轻年龄与高强化相关。
诊断标准与关键数值
- 基于脑沟强化阈值将强化分为高强化与低强化两类,具体阈值原文未报告。
- 钆匹醇与高轴外强化独立相关:3D T1 SE的OR=10.2(P<.001),3D T1 SPGR的OR=10.7(P<.001),2D T1 TSE的OR=14.0(P<.001)。
- 2D FLAIR上对比剂无效应,年轻年龄与高强化相关(P=.022)。
- 观察者间一致性κ=0.530-0.632。
临床应用与阅片要点
- 阅片时需注意钆匹醇增强后T1加权序列上背景轴外强化可能更明显,避免误判为柔脑膜病变。
- 增强后FLAIR不受钆匹醇影响,仍可作为检测真性脑膜疾病的可靠序列。
- 麻醉是3D SE和SPGR上高强化的独立预测因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Gadolinium-based contrast agents (GBCAs) are essential in pediatric neuroimaging, enabling visualization of pathology that disrupts the blood-brain barrier. Gadopiclenol is a new macrocyclic GBCA with higher T1 relaxivity, permitting a 50% dose reduction while maintaining diagnostic quality. However, it is unknown whether this higher relaxivity alters background extra-axial vascular enhancement. We hypothesized that gadopiclenol, despite its lower dose, would increase background enhancement on postcontrast pediatric brain MRI compared with gadoterate meglumine (Gd-DOTA).
MATERIALS AND METHODS: In this retrospective observational study, 302 contrast-enhanced brain MRI studies in patients aged 2-18 years were reviewed: 151 with gadopiclenol (0.05 mmol/kg) and 151 with Gd-DOTA (0.1 mmol/kg). Postcontrast sequences included 3D T1 spin-echo (SE), 3D T1 spoiled gradient-echo (SPGR), 2D T1 TSE, and 2D FLAIR. Two neuroradiologists established binary enhancement categories based on sulcal enhancement thresholds (high versus low). One reader assigned scores for all studies; a second reader evaluated a subset for interobserver agreement. Logistic regression assessed the association between contrast agent and high enhancement, adjusting for age, sex, anesthesia, and scanner field strength.
RESULTS: Gadopiclenol was independently associated with significantly greater odds of high extra-axial enhancement on all T1-weighted sequences: 3D T1 SE (OR = 10.2; P < .001), 3D T1 SPGR (OR = 10.7; P < .001), and 2D T1 TSE (OR = 14.0; P < .001). Anesthesia was also an independent predictor of high enhancement on 3D SE and SPGR. On 2D FLAIR, contrast agent had no effect; instead, younger age was associated with high enhancement (P = .022), with an age-anesthesia interaction suggesting attenuation of this effect under sedation. Interobserver agreement was moderate to substantial (κ = 0.530-0.632).
CONCLUSIONS: Gadopiclenol increases background extra-axial enhancement on T1-weighted postcontrast sequences in pediatric brain MRI, likely reflecting its higher relaxivity. Radiologists should be aware of this effect to avoid misinterpretation as leptomeningeal pathology. Postcontrast FLAIR remains unaffected and continues to serve as a reliable sequence for detecting true meningeal disease.
引用
- Valencia S, Griffin H, Cortes-Albornoz MC, et al. Leptomeningeal Vascularity in Gadopiclenol-Enhanced Pediatric Brain MRI. AJNR Am J Neuroradiol. 2026. PMID: 41015540. doi:10.3174/ajnr.A9020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。